Rejuva Fresh — a U.S.-based developer of advanced medical spa equipment and a rapidly growing presence in the aesthetic device industry — has announced that its PicoPretty Q-Switched ND:YAG Laser Machine has received official approval from Health Canada. The innovation is licensed under number 115678, and the development allows for Canadian medical spas and aesthetic clinics to offer Rejuva Fresh's multi-mode platform for a comprehensive range of non-invasive treatments.
The PicoPretty Q-Switched ND:YAG Laser Machine integrates three distinct technologies, specifically Picosecond, Long Pulse, and Genesis modalities. This allows the innovation to address diverse dermatological concerns including tattoo removal, pigmentation disorders such as melasma and age spots, skin rejuvenation through collagen stimulation, vascular conditions, and hair reduction. The device is engineered with premium components, including a UK-imported Xenon lamp, a 2000W OPT power supply, a USA-made Lamda lens for precise energy delivery.
Image Credit: Rejuva Fresh
What's Driving This Trend
- Multi-mode Aesthetic Platforms
- Consolidated laser systems create white-space for clinics seeking versatile non-invasive treatment menus from a single regulated device.
- Regulatory-ready Spa Equipment
- Health-authorized aesthetic technologies signal market potential for brands that can simplify cross-border clinical adoption and compliance confidence.
- Precision Dermatology Lasers
- Advanced energy delivery components are expanding opportunities around targeted treatments for pigmentation, vascular concerns, tattoo removal, and rejuvenation.
Who This Affects Most
- Medical Aesthetics
- The rise of approved multi-function devices is reshaping service models for med spas and cosmetic clinics competing on treatment breadth.
- Dermatology
- Non-invasive laser platforms support new clinical pathways for addressing common skin concerns with customizable modality-based care.
- Beauty Technology
- Premium hardware integration in aesthetic devices points to emerging differentiation through performance, safety, and professional-grade treatment accessibility.
